Semaglutide works by mimicking GLP-1, a hormone that helps control blood sugar levels by causing the pancreas to release insulin, decreasing the production of glucagon, and slowing down the emptying of the stomach
Compared with injectable formulations, oral small-molecule drugs offer several potential advantages: Greater convenience for patients Easier scalability in large-scale manufacturing More flexibility in cost control Higher potential for broader market penetration These dynamics continue to define oral GLP-1 drug development trends as global pharmaceutical companies accelerate investment in this sector
KLOwen Braces, Fort Collins, Colo, has launched the KLOwen Custom Braces Systemwhat the company calls the worlds first in-office digital custom braces system. According to the company, the system was created to achieve a true straight-wire system that eliminates wire-bending and bracket repositioning
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test examines key variants in GLP-1 receptor pathways, including GLP1R rs6923761, FTO rs9939609, GIPR rs1800437, and MC4R rs17782313
